Go offline with the Player FM app!
2/16/2022 - New Monoclonal Antibody + Variant Updates
Manage episode 320594276 series 2065653
Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-16-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
208 episodes
Manage episode 320594276 series 2065653
Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/2-16-22-episode/eval
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty
Presenting faculty:
Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine
Hosted on Acast. See acast.com/privacy for more information.
208 episodes
Tutti gli episodi
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.